| Michael Benjamin Davidson, DO | |
|
10 Members Way, Suite 400, Dover, NH 03820-5933 | |
| (603) 742-1143 | |
| (603) 749-3509 |
| Full Name | Michael Benjamin Davidson |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Endocrinology, Diabetes & Metabolism |
| Location | 10 Members Way, Dover, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225109168 | NPI | - | NPPES |
| 3076450 | Medicaid | NH | |
| 1225109168 | Medicaid | ME | |
| P00775096 | Other | NH | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 13393 (New Hampshire) | Primary |
| Entity Name | Wentworth Douglass Physician Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447352430 PECOS PAC ID: 5496749848 Enrollment ID: O20040409000433 |
News Archive
Aerocrine: January - March 2011: Net sales rose by 24% to SEK 22.2m. Adjusted for currency fluctuations, net sales rose by 38%
MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza vaccine (LAIV) against the 2009 H1N1 influenza virus. This brings HHS orders to date to more than 40 million vaccine doses, with a total cumulative contract value of approximately $453 million.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.
Modifying the risk of peripheral arterial disease (or PAD)-with healthy lifestyle changes-remains vital to one's health, note researchers in a recent issue of the Journal of Vascular and Interventional Radiology. And while PAD can progress and worsen over time, there is not enough evidence yet to advocate minimally invasive treatment in patients who have had a narrowing or blockage of a leg artery but showing no signs or symptoms of the disease, say Irish researchers in a retrospective study of more than 900 individuals.
On Friday, an appeals court temporarily stayed a judge's ban on the federal government's funding of embryonic stem-cell research, the The Associated Press/The Philadelphia Inquirer reports. "The National Institutes of Health said it was resuming its own research and would again evaluate applications from scientists who are seeking taxpayer money to do the work, a process that has been frozen since late last month."
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Benjamin Davidson, DO 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 742-1143 | Michael Benjamin Davidson, DO 10 Members Way, Suite 400, Dover, NH 03820-5933 Ph: (603) 742-1143 |
News Archive
Aerocrine: January - March 2011: Net sales rose by 24% to SEK 22.2m. Adjusted for currency fluctuations, net sales rose by 38%
MedImmune announced today that the U.S. Department of Health and Human Services (HHS) has placed an order for an additional 29 million doses of its live attenuated influenza vaccine (LAIV) against the 2009 H1N1 influenza virus. This brings HHS orders to date to more than 40 million vaccine doses, with a total cumulative contract value of approximately $453 million.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.
Modifying the risk of peripheral arterial disease (or PAD)-with healthy lifestyle changes-remains vital to one's health, note researchers in a recent issue of the Journal of Vascular and Interventional Radiology. And while PAD can progress and worsen over time, there is not enough evidence yet to advocate minimally invasive treatment in patients who have had a narrowing or blockage of a leg artery but showing no signs or symptoms of the disease, say Irish researchers in a retrospective study of more than 900 individuals.
On Friday, an appeals court temporarily stayed a judge's ban on the federal government's funding of embryonic stem-cell research, the The Associated Press/The Philadelphia Inquirer reports. "The National Institutes of Health said it was resuming its own research and would again evaluate applications from scientists who are seeking taxpayer money to do the work, a process that has been frozen since late last month."
› Verified 1 days ago
Dr. Mark Lee Dick, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Fl 5, Dover, NH 03820 Phone: 603-609-6800 | |
Mrs. Jhansi Lakshmi Maradana, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Ste 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Ravi Teja Pasam, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2503 Fax: 603-740-2497 | |
Paul C Tung, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 10 Members Way, Suite 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Amy Claire Bessnow, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-740-2694 | |
Dylan Thomas, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Ste 400, Dover, NH 03820 Phone: 603-742-1143 Fax: 603-749-3509 | |
Alison M Sollee, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 10 Members Way Fl 5, Dover, NH 03820 Phone: 603-609-6800 |